Risk of cardiovascular events associated with pathophysiological phenotypes of type 2 diabetes.
Jacob Volmer StidsenDiana Hedevang ChristensenJan Erik HenriksenKurt HøjlundMichael Hecht OlsenReimar Wernick ThomsenLotte Brix ChristensenJens Steen NielsenThomas Bastholm OlesenHenning Beck-NielsenPublished in: European journal of endocrinology (2022)
Simple phenotyping based on insulin sensitivity and beta-cell function predicts distinct future risks of cardiovascular events and death in patients with type 2 diabetes. These results suggest that precision medicine according to underlying type 2 pathophysiology potentially can reduce diabetes complications.